|Articles|September 12, 2022
Characterizing mRNA using SEC-MALS
Author(s)Wyatt
SEC-MALS quantifies biophysical attributes of mRNA, including molar mass, percent aggregates, Rg and Rh, and how they are affected by formulation and storage conditions.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
3
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
4
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
5